174 related articles for article (PubMed ID: 16652149)
21. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
Smith PC; Cáceres M; Martinez J
J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
[TBL] [Abstract][Full Text] [Related]
22. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
[TBL] [Abstract][Full Text] [Related]
23. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
24. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
26. Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.
Tanabe S; Kreutz B; Suzuki N; Kozasa T
Methods Enzymol; 2004; 390():285-94. PubMed ID: 15488184
[TBL] [Abstract][Full Text] [Related]
27. RhoA signaling in phorbol ester-induced apoptosis.
Chang ZF; Lee HH
J Biomed Sci; 2006 Mar; 13(2):173-80. PubMed ID: 16496227
[TBL] [Abstract][Full Text] [Related]
28. Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.
Chikumi H; Barac A; Behbahani B; Gao Y; Teramoto H; Zheng Y; Gutkind JS
Oncogene; 2004 Jan; 23(1):233-40. PubMed ID: 14712228
[TBL] [Abstract][Full Text] [Related]
29. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner.
Cetin S; Leaphart CL; Li J; Ischenko I; Hayman M; Upperman J; Zamora R; Watkins S; Ford HR; Wang J; Hackam DJ
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1347-58. PubMed ID: 17272518
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
[TBL] [Abstract][Full Text] [Related]
33. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
34. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways.
Debruyne PR; Bruyneel EA; Karaguni IM; Li X; Flatau G; Müller O; Zimber A; Gespach C; Mareel MM
Oncogene; 2002 Oct; 21(44):6740-50. PubMed ID: 12360401
[TBL] [Abstract][Full Text] [Related]
35. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
[TBL] [Abstract][Full Text] [Related]
36. Preliminary crystallographic analysis of the complex of the human GTPase RhoA with the DH/PH tandem of PDZ-RhoGEF.
Oleksy A; Barton H; Devedjiev Y; Purdy M; Derewenda U; Otlewski J; Derewenda ZS
Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):740-2. PubMed ID: 15039571
[TBL] [Abstract][Full Text] [Related]
37. Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.
Albrecht M; Doroszewicz J; Gillen S; Gomes I; Wilhelm B; Stief T; Aumüller G
Prostate; 2004 Jan; 58(1):82-94. PubMed ID: 14673956
[TBL] [Abstract][Full Text] [Related]
38. The Lsc RhoGEF mediates signaling from thromboxane A2 to actin polymerization and apoptosis in thymocytes.
Harenberg A; Girkontaite I; Giehl K; Fischer KD
Eur J Immunol; 2005 Jun; 35(6):1977-86. PubMed ID: 15884057
[TBL] [Abstract][Full Text] [Related]
39. Involvement of neutral endopeptidase in neoplastic progression.
Sumitomo M; Shen R; Nanus DM
Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
[TBL] [Abstract][Full Text] [Related]
40. The role of RhoA in the regulation of cell morphology and motility.
Tkach V; Bock E; Berezin V
Cell Motil Cytoskeleton; 2005 May; 61(1):21-33. PubMed ID: 15776463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
